Literature DB >> 1971449

Antagonism of the hypothermic effect of clozapine in mice by centrally-active alpha 2-adrenergic antagonists and alpha 1-adrenergic agonists.

M K Menon1, R L Lloyd, L J Fitten.   

Abstract

Hypothermia induced by either clozapine or clonidine in mice was blocked by the alpha 2-adrenergic antagonists yohimbine, idazoxan, CH-38083, SKF 86466, and L-657,743. These effects were dose related, and the ID50 values for inhibition of clozapine- or clonidine-induced hypothermia were fairly comparable. The order of potency for blocking clonidine-induced hypothermia was: L-657,743 greater than CH-38083 greater than yohimbine greater than idazoxan greater than SKF 86466. A very similar blockade hierarchy for clozapine-induced hypothermia was observed, with the order of the two most effective compounds being reversed. Hypothermia induced by either compound was not blocked by the peripherally-acting, selective alpha 2-adrenergic antagonist, L-659,066, indicating that blockade by the other compounds occurred centrally. The centrally-acting, alpha 1-adrenergic agonists St 587, cirazoline, and SKF 89748 were very effective in blocking the response to clozapine, but ineffective in antagonizing clonidine-induced hypothermia. The ED50 values for the blockade of this response to clozapine, however, did not correlate with their reported potencies in stimulating either peripheral or central alpha 1-adrenergic receptors. This indicates that clozapine-induced hypothermia in mice is not a suitable model for evaluating the properties of central alpha 1-adrenergic compounds. Moreover, since the clonidine-induced hypothermia is not influenced by alpha 1-adrenergic agonists, this paradigm is preferable to clozapine-induced hypothermia in the assessment of alpha 2-adrenergic antagonism The ability of alpha 2-adrenergic antagonists to block clozapine-induced hypothermia may result from the central overflow of norepinephrine, which is known to be brought about by this group of compounds.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971449     DOI: 10.1007/bf02253720

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Antagonism of alpha-adrenoceptor agonist-induced antinociception in the rat.

Authors:  A G Hayes; M Skingle; M B Tyers
Journal:  Neuropharmacology       Date:  1986-04       Impact factor: 5.250

2.  An in vivo pharmacological method for the quantitative evaluation of the central effects of alpha 1 adrenoceptor agonists and antagonists.

Authors:  M K Menon; C K Kodama; A S Kling; J Fitten
Journal:  Neuropharmacology       Date:  1986-05       Impact factor: 5.250

3.  Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. III. Comparison of central and peripheral alpha-1 and alpha-2 adrenoceptors.

Authors:  A de Jonge; P B Timmermans; P A van Zwieten
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

4.  3H-Clozapine binding to rat brain membranes.

Authors:  D Hauser; A Closse
Journal:  Life Sci       Date:  1978-08-14       Impact factor: 5.037

5.  Receptor interactions of imidazolines. IX. Cirazoline is an alpha-1 adrenergic agonist and an alpha-2 adrenergic antagonist.

Authors:  R R Ruffolo; J E Waddell
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

6.  Pre- and postsynaptic alpha-adrenoceptor antagonism by neuroleptics in vivo.

Authors:  E N Petersen
Journal:  Eur J Pharmacol       Date:  1981-02-19       Impact factor: 4.432

7.  Alpha 1-adrenoceptor-mediated vasoconstriction in vivo to enantiomers of SK & F 89748-A.

Authors:  P B Timmermans; W D Matthews; R M Demarinis; J P Hieble; M J Mathy; H N Doods; M J Thoolen; A De Jonge; B Wilffert; P A Van Zwieten
Journal:  Eur J Pharmacol       Date:  1984-05-18       Impact factor: 4.432

8.  Alpha 2-adrenoceptor blocking properties of the alpha 1-selective agonist 2-(2-chloro-5-trifluoromethylphenylimino)imidazolidine (St 587).

Authors:  L Pichler; W Kobinger
Journal:  Arzneimittelforschung       Date:  1985

9.  A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.

Authors:  B V Clineschmidt; D J Pettibone; V J Lotti; H B Hucker; B M Sweeney; D R Reiss; E V Lis; J R Huff; J Vacca
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

10.  Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat.

Authors:  G Paalzow; L Paalzow
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

View more
  2 in total

1.  Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivity.

Authors:  Jodi E Gresack; Victoria B Risbrough
Journal:  Int J Neuropsychopharmacol       Date:  2010-12-21       Impact factor: 5.176

2.  Clozapine and olanzapine, but not haloperidol, reverse cold-induced and lipopolysaccharide-induced cutaneous vasoconstriction.

Authors:  William Walter Blessing
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.